Campbell & CO Investment Adviser LLC Cara Therapeutics, Inc. Transaction History

Campbell & CO Investment Adviser LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$4.89 - $12.27 $78 - $196	16 Added 0.1%	15,842 $77,000
Q4 2022 Feb 14, 2023	BUY	$8.88 - $12.77 $140,534 - $202,098	15,826 New	15,826 $169,000
Q4 2021 Feb 10, 2022	SELL	$11.99 - $18.14 $510,774 - $772,764	-42,600 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$11.55 - $16.06 $492,030 - $684,156	42,600 New	42,600 $658,000
Q4 2020 Feb 09, 2021	SELL	$12.72 - $16.16 $173,360 - $220,244	-13,629 Closed	0 $0

Q3 2020 Oct 15, 2020	BUY	$12.34 - $17.92 $168,181 - $244,231	13,629 New	13,629 $173,000

102

21.5M

50K

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.